Effects of genetic variants in ADCY5, GIPR, GCKR and VPS13C on early impairment of glucose and insulin metabolism in children

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Windholz, Jan ^a   Kovacs, Peter ^a   Tönjes, Anke ^a,b   Dittrich, Kathrin ^a   Blüher, Susann ^a   Kiess, Wieland ^a   Stumvoll, Michael ^a,b   Körner, Antje ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; GLUCOSE; INSULIN; PROTEIN ADY5; PROTEIN GCKR; PROTEIN GIPR; PROTEIN VPS 13C; UNCLASSIFIED DRUG; ADENYLATE CYCLASE; ADENYLYL CYCLASE TYPE V; GASTRIC INHIBITORY POLYPEPTIDE RECEPTOR; GCKR PROTEIN, HUMAN; HORMONE RECEPTOR; PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; VPS13C PROTEIN, HUMAN;

ADY5 GENE; ARTICLE; BODY MASS; CAUCASIAN; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; GCKR GENE; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GIPR GENE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; INSULIN BLOOD LEVEL; INSULIN METABOLISM; INSULIN RELEASE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; OBESITY; ORAL GLUCOSE TOLERANCE TEST; SCHOOL CHILD; VPS 13C GENE; ALLELE; DEMOGRAPHY; GENETIC PREDISPOSITION; GENETICS; METABOLISM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENYLATE CYCLASE; ALLELES; CHILD; DEMOGRAPHY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GLUCOSE; HUMANS; INSULIN; MALE; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS; RECEPTORS, GASTROINTESTINAL HORMONE; RISK FACTORS;

EID: 79960317276     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022101     Document Type: Article

References (17)

1. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, et al. (2010) New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42: 105-116.
2. Saxena R, Hivert MF, Langenberg C, Tanaka T, Pankow JS, et al. (2010) Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet 42: 142-148.
3. Körner A, Berndt J, Stumvoll M, Kiess W, Kovacs P, (2007) TCF7L2 gene polymorphisms confer an increased risk for early impairment of glucose metabolism and increased height in obese children. J Clin Endocrinol Metab 92: 1956-1960.
4. Körner A, Neef M, Friebe D, Erbs S, Kratzsch J, et al. (2010) Vaspin is related to gender, puberty and deteriorating insulin sensitivity in children. Int J Obes (Lond) 2010;-Epub ahead of print.
5. Kromeyer-Hauschild K, Wabitsch M, Geller F, Ziegler A, Geiß HC, et al. (2001) Perzentilen für den Body Mass Index für das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. (Centiles for body mass index for children and adolescents derived from distinct independent German cohorts). Monatsschr Kinderheilkd 149: 807-818.
6. Ortiz-Capisano MC, Ortiz PA, Harding P, Garvin JL, Beierwaltes WH, (2007) Adenylyl cyclase isoform v mediates renin release from juxtaglomerular cells. Hypertension 49: 618-624.
7. Hu CL, Chandra R, Ge H, Pain J, Yan L, et al. (2009) Adenylyl cyclase type 5 protein expression during cardiac development and stress. Am J Physiol Heart Circ Physiol 297: H1776-H1782.
8. de Gortari P, Mengod G, (2010) Dopamine D1, D2 and mu-opioid receptors are co-expressed with adenylyl cyclase 5 and phosphodiesterase 7B mRNAs in striatal rat cells. Brain Res 1310: 37-45.
9. Goran MI, Gower BA, (2001) Longitudinal study on pubertal insulin resistance. Diabetes 50: 2444-2450.
10. Freathy RM, Mook-Kanamori DO, Sovio U, Prokopenko I, Timpson NJ, et al. (2010) Variants in ADCY5 and near CCNL1 are associated with fetal growth and birth weight. Nat Genet 42: 430-435.
11. Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K, et al. (1993) Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 36: 62-67.
12. Stumvoll M, Goldstein BJ, van Haeften TW, (2005) Type 2 diabetes: principles of pathogenesis and therapy. Lancet 365: 1333-1346.
13. Ahren B, Pacini G, (2004) Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies. Eur J Endocrinol 150: 97-104.
14. Ingelsson E, Langenberg C, Hivert MF, Prokopenko I, Lyssenko V, et al. (2010) Detailed physiologic characterization reveals diverse mechanisms for novel genetic Loci regulating glucose and insulin metabolism in humans. Diabetes 59: 1266-1275.
15. Povel CM, Feskens EJ, Imholz S, Blaak EE, Boer JM, et al. (2010) Glucose levels and genetic variants across transcriptional pathways: interaction effects with BMI. Int J Obes (Lond) 34: 840-845.
16. Körner A, Kratzsch J, Gausche R, Schaab M, Erbs S, et al. (2007) New predictors of the metabolic syndrome in children-role of adipocytokines. Pediatr Res 61: 640-645.
17. Velayos-Baeza A, Vettori A, Copley RR, Dobson-Stone C, Monaco AP, (2004) Analysis of the human VPS13 gene family. Genomics 84: 536-549.